| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/22/1992 | EP0495484A1 Novel benzo [5,6] cyclohepta [1,2-b] pyridine derivatives and antiallergic agents comprising same |
| 07/22/1992 | EP0495473A1 New diazepines substituted in position 6, process for their production and their use as drugs |
| 07/21/1992 | US5132453 N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body |
| 07/21/1992 | US5132403 Forms complex with interleukin-6 receptor; genetic engineering |
| 07/21/1992 | US5132328 Lipoxygenase inhibitors as antiinflammatory agents or antiallergens |
| 07/21/1992 | US5132222 Established cell line, kml1-7, which produces b-cell differentiation factor (bcdf) |
| 07/21/1992 | US5132122 Process for producing a lactic acid drink |
| 07/21/1992 | US5132109 Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof |
| 07/21/1992 | CA1305480C Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
| 07/21/1992 | CA1305478C Naphthyridine and pyridopyrazine compounds and pharmaceutical usage thereof |
| 07/21/1992 | CA1305424C Use of 15-deoxyspergualine as a pharmaceutical |
| 07/18/1992 | CA2058651A1 Sulphonamide derivatives |
| 07/17/1992 | CA2059353A1 Diazepines substituted in the 6-position, processes for their preparation and their preparation and their use as pharmaceutical compositions |
| 07/16/1992 | CA2058254A1 Benzodioxole derivatives |
| 07/15/1992 | EP0494848A1 Method of removing endotoxins |
| 07/15/1992 | EP0494621A1 Substituted alkenoic acid and its derivatives |
| 07/15/1992 | EP0494224A1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
| 07/15/1992 | EP0378549B1 Pharmaceutical composition for preventing and treating bacterial or viral diseases |
| 07/15/1992 | CN1062735A T-butyloxycarbonyl-l-tyrosyl-peptidoglycan monomer and 125 i-labelled derivative thereof, their preparation and use |
| 07/15/1992 | CN1017425B Process for the preparation of heterocyclic amide derivatives |
| 07/14/1992 | US5130485 N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents |
| 07/14/1992 | US5130335 Tetralin esters of phenols or benzoic acids having retinoid like activity |
| 07/14/1992 | US5130323 Anticoagulants, thromboxane A2 antagonist and enzyme inhibitor for treatment of nephtitis and asthma |
| 07/14/1992 | US5130317 Immunosuppressants and fibrosuppressants for metabolism of collagen |
| 07/14/1992 | US5130302 Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same |
| 07/14/1992 | US5130245 Insert containing dna coding system; treatment of diseases causes by superoxide radicals |
| 07/14/1992 | US5130128 Hyperimmunized against antigens found in honey |
| 07/14/1992 | CA1305151C Antiallergy and antiinflammatory agents |
| 07/14/1992 | CA1305150C Derivatives of spiro (4,5) decane, process for their preparation and pharmaceutical compositions containing the same |
| 07/14/1992 | CA1305147C Benzo¬5,6|cycloheptapyridines, compositions and methods of use |
| 07/11/1992 | CA2058884A1 Substituted alkenoic acid and its derivatives |
| 07/10/1992 | WO1992012141A1 N-hydroxyurea derivatives as antiallergy and antiinflammatory agents |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/09/1992 | WO1992011275A1 13-dimethyl fr-900506 derivative and the use as an immunosuppressive agent |
| 07/08/1992 | WO1992012161A1 Novel pyrimido-benzothiazines |
| 07/08/1992 | WO1992011860A1 Topical formulation of cyclosporine |
| 07/08/1992 | EP0494063A2 Method for inhibiting IgE production |
| 07/08/1992 | EP0493682A2 Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans |
| 07/08/1992 | EP0493662A1 Use of superoxide dismutase for the preparation of drugs for the prophylaxis and/or treatment of organ failure in risk patients having a polytrauma due to an accident |
| 07/08/1992 | EP0493498A1 Medicament comprising antamanide |
| 07/08/1992 | CA2099558A1 Pyrimido-benzothiazines |
| 07/08/1992 | CA2077647A1 Topical formulation of cyclosporine |
| 07/07/1992 | US5128470 Aromatic carboxamides |
| 07/07/1992 | US5128369 Arylalkylamine derivatives |
| 07/07/1992 | US5128324 Transdermally applicable pharmaceutical preparations with sterolines and/or spiroketalines |
| 07/01/1992 | EP0492920A1 Chimaeric influenza-HIV vaccine |
| 07/01/1992 | EP0492478A2 Tert-butyloxycarbonyl-L-tyrosyl-peptidoglycan monomer and 125 I-labelled derivative thereof, their preparation and use |
| 07/01/1992 | EP0492448A1 Monoclonal antibodies against human tumor necrosis factor alpha |
| 07/01/1992 | EP0492430A1 Oxetanocin derivative having imidazole base group |
| 07/01/1992 | EP0492178A2 Naphthoic acid derivative |
| 07/01/1992 | EP0491913A1 Chinese herbal extracts in the treatment of hiv related disease |
| 07/01/1992 | EP0491844A1 Peptides including ctl epitopes of hiv proteins and use thereof |
| 07/01/1992 | EP0491829A1 Method for immune system activation. |
| 07/01/1992 | EP0491797A1 Novel macrocyclic compounds and novel method of treatment |
| 07/01/1992 | EP0491751A1 Antiviral tetrahydroimidazo 1,4]benzodiazepines |
| 07/01/1992 | CN1062291A Pharmaceutical agents |
| 06/30/1992 | US5126365 Bicyclic derivatives |
| 06/30/1992 | US5126354 Leukotriene synthesis-inhibiting disubstituted (quinolin-2-yl-methoxy) phenylacetic acid derivatives |
| 06/30/1992 | US5126341 Anti-inflammatory 1,8-naphthyridin-2-one derivatives |
| 06/30/1992 | US5126322 Pancreatic secretory tryspin inhibitor and variants thereof produced by a recombinant host therefore and pharmaceutical use thereof |
| 06/30/1992 | US5126149 Tellurium tetrahalide for treament of autoimmune deficiency syndrome |
| 06/30/1992 | CA1304391C Lipoxygenase inhibiting compounds |
| 06/28/1992 | WO1992012171A1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 06/28/1992 | WO1992011858A1 Hexa- and heptapeptide anaphylatoxin-receptor ligands |
| 06/28/1992 | CA2095359A1 Hexa- and heptapeptide anaphylatoxin receptor ligands |
| 06/28/1992 | CA2076877A1 Synthetic peptides with immunomodulating activity and their preparation |
| 06/28/1992 | CA2058457A1 Method for inhibiting ige production |
| 06/25/1992 | WO1992010498A1 Novel csaids |
| 06/25/1992 | WO1992010497A1 ENANTIOMERICALLY PURE β-D-(-)-DIOXOLANE-NUCLEOSIDES |
| 06/25/1992 | WO1992010491A1 Antiallergic compounds |
| 06/25/1992 | WO1992009586A1 Active oxygen inhibitor |
| 06/25/1992 | WO1992006992A3 New process for biophosphorylating organic compounds |
| 06/25/1992 | CA2590125A1 Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides |
| 06/25/1992 | CA2057963A1 Chimaeric influenza-hiv vaccine |
| 06/24/1992 | EP0491628A2 Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines |
| 06/24/1992 | EP0491114A1 A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity |
| 06/24/1992 | EP0491032A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
| 06/24/1992 | EP0490995A1 Method for producing soluble glucans |
| 06/24/1992 | EP0490975A1 Interleukin-4 receptors |
| 06/24/1992 | CN1062171A Process for preparing sulphate derivative of galactan extracted from klebsiella |
| 06/24/1992 | CN1062140A Process for preparing benzoxazin-and thiazin compounds |
| 06/24/1992 | CN1062138A Synergism of hiv reverse transcriptase inhibitors |
| 06/23/1992 | US5124342 4-hydroxythiazoles as 5-lipoxygenase inhibitors |
| 06/23/1992 | US5124336 Azabenzimidazole derivatives which are thromboxane receptor antagonists |
| 06/23/1992 | US5124322 Antiarthritic agents |
| 06/23/1992 | CA1304024C Covalently linked polypeptide cell modulators |
| 06/23/1992 | CA1303994C2 Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds |
| 06/22/1992 | WO1992011260A1 Xanthine derivatives |
| 06/22/1992 | CA2098846A1 Xanthine derivatives |
| 06/22/1992 | CA2058247A1 Tert-butyloxcarbonyl-1-tyrosyl-peptidoglycan monomer and 1251-labelled derivative thereof, their preparation and use |
| 06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
| 06/18/1992 | WO1992011029A1 Suppression of immune responses with oligomeric forms of antigen of controlled chemistry |
| 06/18/1992 | CA2098281A1 Suppression of immune responses of oligomeric forms of antigen of controlled chemistry |
| 06/17/1992 | EP0490649A1 A physical form of N-[4-[5-(cyclopentyloxycarbonylamino)-1-methyl-indol-3-ylmethyl]-3-methoxybenzoyl]-2-methylbenzenesulfonamide, a process for its preparation and pharmaceutical compositions containing it |
| 06/17/1992 | EP0490648A1 Pharmaceutical agents |
| 06/17/1992 | EP0490434A1 Labelled, modified oligonucleotides |
| 06/17/1992 | EP0490181A1 Use of xanthines for preparation of a medicament having immunosuppressing activity |
| 06/17/1992 | EP0490006A1 Pharmaceutical compositions for the treatment of B-cell malignancies |
| 06/17/1992 | EP0489837A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
| 06/17/1992 | EP0489831A1 Substituted quinolines, their preparation and their use as lipoxygenase inhibitors and/or leukotriene antagonists |